A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19 | NEJM
Original Article from The New England Journal of Medicine — A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
Original Article from The New England Journal of Medicine — A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
Illustrated Glossary from The New England Journal of Medicine
Illustrated Glossary from The New England Journal of Medicine
Illustrated Glossary from The New England Journal of Medicine
Illustrated Glossary from The New England Journal of Medicine
In an analysis of the primary outcome of this phase 3 trial, patients with early relapsed or refractory large B-cell lymphoma who received axicabtagene ciloleucel…
Illustrated Glossary from The New England Journal of Medicine
Illustrated Glossary from The New England Journal of Medicine
In an analysis of the primary outcome of this phase 3 trial, patients with early relapsed or refractory large B-cell lymphoma who received axicabtagene ciloleucel…
Illustrated Glossary from The New England Journal of Medicine
Illustrated Glossary from The New England Journal of Medicine